Activation of Stat3 transcription factor by Herpesvirus Saimiri STP-A oncoprotein

Journal of Virology

Volumn 78, Issue 12, 2004, Pages 6489-6497

  Chung, Young Hwa ^a,b   Cho, Nam Hyuk ^a   Garcia, Maria Ines ^a   Lee, Sun Hwa ^a   Feng, Pinghui ^a   Jung, Jae U ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; LAT PROTEIN; ONCOPROTEIN; PROTEIN BCL XL; PROTEIN TYROSINE KINASE; SAIMIRI TRANSFORMING PROTEIN A; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SURVIVAL; COMPLEX FORMATION; HERPES VIRUS SAIMIRI; LYMPHOID CELL; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; TRANSCRIPTION REGULATION; VIRUS ACTIVATION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; CELL LINE; CELL TRANSFORMATION, VIRAL; COS CELLS; DNA-BINDING PROTEINS; HERPESVIRUS 2, SAIMIRIINE; HUMANS; MICE; NIH 3T3 CELLS; ONCOGENE PROTEINS, VIRAL; PHOSPHOTRANSFERASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSFECTION;

EID: 2642581525     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.12.6489-6497.2004     Document Type: Article

References (39)

1. Biesinger, B., I. Muller-Fleckenstein, B. Simmer, G. Lang, S. Wittmann, E. Platzer, R. C. Desrosiers, and B. Fleckenstein. 1992. Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc. Natl. Acad. Sci. USA 89:3116-3119.
2. Biesinger, B., J. J. Trimble, R. C. Desrosiers, and B. Fleckenstein. 1990. The divergence between two oncogenic Herpesvirus saimiri strains in a genomic region related to the transforming phenotype. Virology 176:505-514.
3. Bowman, T., M. A. Broome, D. Sinibaldi, W. Wharton, W. J. Pledger, J. M. Sedivy, R. Irby, T. Yeatman, S. A. Courtneidge, and R. Jove. 2001. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc. Natl. Acad. Sci. USA 98:7319-7324.
4. Bromberg, J. F., C. M. Horvath, D. Besser, W. W. Lathem, and J. E. Darnell, Jr. 1998. Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol 18:2553-2558.
5. Bromberg, J. F., M. H. Wrzeszczynska, G. Devgan, Y. Zhao, R. G. Pestell, C. Albanese, and J. E. Darnell, Jr. 1999. Stat3 as an oncogene. Cell 98:295-303.
6. Catlett-Falcone, R., W. S. Dalton, and R. Jove. 1999. STAT proteins as novel targets for cancer therapy. Signal transducer and activator of transcription. Curr. Opin. Oncol. 11:490-496.
7. Catlett-Falcone, R., T. H. Landowski, M. M. Oshiro, J. Turkson, A. Levitzki, R. Savino, G. Ciliberto, L. Moscinski, J. L. Fernandez-Luna, G. Nunez, W. S. Dalton, and R. Jove. 1999. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10:105-115.
8. Chen, H., L. Hutt-Fletcher, L. Cao, and S. D. Hayward. 2003. A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. J. Virol. 77:4139-4148.
9. Choi, J. K., S. Ishido, and J. U. Jung. 2000. The collagen repeat sequence is a determinant of the degree of herpesvirus saimiri STP transforming activity. J. Virol. 74:8102-8110.
10. Courtneidge, S. A., and J. M. Bishop. 1982. Transit of pp60v-src to the plasma membrane. Proc. Natl. Acad. Sci. USA 79:7117-7121.
11. Damania, B., J. K. Choi, and J. U. Jung. 2000. Signaling activities of gammaherpesvirus membrane proteins. J. Virol. 74:1593-1601.
12. Damania, B., and J. U. Jung. 2001. Comparative analysis of the transforming mechanisms of Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, and herpesvirus saimiri. Adv. Cancer Res. 80:51-82.
13. Darnell, J. E., Jr. 1997. STATs and gene regulation. Science 277:1630-1635.
14. Desrosiers, R. C., A. Bakker, J. Kamine, L. A. Falk, R. D. Hunt, and N. W. King. 1985. A region of the Herpesvirus saimiri genome required for oncogenicity. Science 228:184-187.
15. Desrosiers, R. C., R. L. Burghoff, A. Bakker, and J. Kamine. 1984. Construction of replication-competent herpesvirus saimiri deletion mutants. J. Virol. 49:343-348.
16. Desrosiers, R. C., D. P. Silva, L. M. Waldron, and N. L. Letvin. 1986. Nononcogenic deletion mutants of herpesvirus saimiri are defective for in vitro immortalization. J. Virol. 57:701-705.
17. Epling-Burnette, P. K., B. Zhong, F. Bai, K. Jiang, R. D. Bailey, R. Garcia, R. Jove, J. Y. Djeu, T. P. Loughran, Jr., and S. Wei. 2001. Cooperative regulation of Mcl-1 by Janus kinase/Stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neatrophils. J. Immunol. 166:7486-7495.
18. Fickenscher, H., and B. Fleckenstein. 2001. Herpesvirus saimiri. Philos. Trans. R. Soc. Lond. B 356:545-567.
19. Garcia, R., T. L. Bowman, G. Niu, H. Yu, S. Minton, C. A. Muro-Cacho, C. E. Cox, R. Falcone, R. Fairclough, S. Parsons, A. Laudano, A. Gazit, A. Levitzki, A. Kraker, and R. Jove. 2001. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20:2499-2513.
20. Garcia, R., C. L. Yu, A. Hudnall, R. Catlett, K. L. Nelson, T. Smithgall, D. J. Fujita, S. P. Ethier, and R. Jove. 1997. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ. 8:1267-1276.
21. Gibbons, I. R., D. J. Asai, N. S. Ching, G. J. Dolecki, G. Mocz, C. A. Phillipson, H. Ren, W. J. Tang, and B. H. Gibbons. 1991. A PCR procedure to determine the sequence of large polypeptides by rapid walking through a cDNA library. Proc. Natl. Acad. Sci. USA 88:8563-8567.
22. Gires, O., F. Kohlhuber, E. Kilger, M. Baumann, A. Kieser, C. Kaiser, R. Zeidler, B. Scheffer, M. Ueffing, and W. Hammerschmidt. 1999. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J. 18:3064-3073.
23. Hobbs, S., S. Jitrapakdee, and J. C. Wallace. 1998. Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1α promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins. Biochem. Biophys. Res. Commun. 252:368-372.
24. Horvath, C. M., Z. Wen, and J. E. Darnell, Jr. 1995. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 9:984-994.
25. Jove, R. 2000. Preface: STAT signaling. Oncogene 19:2466-2467.
26. Jung, J. U., J. K. Choi, A. Ensser, and B. Biesinger. 1999. Herpesvirus saimiri as a model for gammaherpesvirus oncogenesis. Semin. Cancer Biol. 9:231-239.
27. Jung, J. U., and R. C. Desrosiers. 1994. Distinct functional domains of STP-C488 of herpesvirus saimiri. Virology 204:751-758.
28. Jung, J. U., and R. C. Desrosiers. 1991. Identification and characterization of the herpesvirus saimiri oncoprotein STP-C488. J. Virol. 65:6953-6960.
29. Kisseleva, T., S. Bhattacharya, J. Braunstein, and C. W. Schindler. 2002. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285:1-24.
30. Lee, H., J. K. Choi, M. Li, K. Kaye, E. Kieff, and J. U. Jung. 1999. Role of cellular tumor necrosis factor receptor-associated factors in NF-κB activation and lymphocyte transformation by herpesvirus saimiri STP. J. Virol. 73:3913-3919.
31. Lee, H., J. J. Trimble, D. W. Yoon, D. Regier, R. C. Desrosiers, and J. U. Jung. 1997. Genetic variation of herpesvirus saimiri subgroup A transforming protein and its association with cellular src. J. Virol. 71:3817-3825.
32. Medveczky, P., E. Szomolanyi, R. C. Desrosiers, and C. Mulder. 1984. Classification of herpesvirus saimiri into three groups based on extreme variation in a DNA region required for oncogenicity. J. Virol. 52:938-944.
33. Murthy, S. C., J. J. Trimble, and R. C. Desrosiers. 1989. Deletion mutants of herpesvirus saimiri define an open reading frame necessary for transformation. J. Virol. 63:3307-3314.
34. Schreiner, S. J., A. P. Schiavone, and T. E. Smithgall. 2002. Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain. J. Biol. Chem. 277:45680-45687.
35. Sinibaldi, D., W. Wharton, J. Turkson, T. Bowman, W. J. Pledger, and R. Jove. 2000. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19:5419-5427.
36. Szomolanyi, E., P. Medveczky, and C. Mulder. 1987. In vitro immortalization of marmoset cells with three subgroups of herpesvirus saimiri. J. Virol. 61:3485-3490.
37. Turkson, J., T. Bowman, R. Garcia, E. Caldenhoven, R. P. De Groot, and R. Jove. 1998. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 18:2545-2552.
38. Yoshida, T., T. Hanada, T. Tokuhisa, K. Kosai, M. Sata, M. Kohara, and A. Yoshimura. 2002. Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J. Exp. Med. 196:641-653.
39. Zhang, Y., J. Turkson, C. Carter-Su, T. Smithgall, A. Levitzki, A. Kraker, J. J. Krolewski, P. Medveczky, and R. Jove. 2000. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity. J. Biol. Chem. 275:24935-24944.